PharmaCielo Ltd. has made some key appointments to its management team and board of directors: With scalable cultivation and processing infrastructure in place and the Company's public listing achieved, Anthony Wile has stepped down as interim chief executive officer and from the Board as a director, returning to his role as chief executive officer of Grupo Jaque Ltd. Mr. Wile will continue to work with the Company, serving as a special consultant, with efforts focused on actively supporting the long-term global strategy and expanding international opportunities; David Attard has been appointed chief executive officer; Dr. Delon Human has been appointed global head, health and innovation; and Doug Bache has been appointed to the Board, and will serve as chair of the Audit Committee. A member of the board of directors of PharmaCielo Ltd. since 2015, Mr. Attard was most recently an officer and director of President's Choice Service Inc. and officer of President's Choice Bank. Dr. Human, MBChB, MPraxMed, MFGP, DCH, MBA, a member of the board of directors of PharmaCielo Ltd. since 2016, is a published author, international lecturer and health care consultant specializing in global health strategy, corporate and product transformation, harm reduction and health communication, as president and founder of Health Diplomats plc.

He has acted as adviser to the WHO director-general and to secretary-general of the UN Ban Ki-moon. Until 2014 he served as secretary-general and special envoy to WHO /UN of the International Food and Beverage Alliance, a group of leading food and non-alcoholic beverage companies with a global presence. Mr. Bache, during the past 12 years, has provided corporate finance and strategy consulting and management services to mining companies and previously he held senior management positions with Vale/Inco Limited and North American Palladium Ltd. During a 10-year career in investment and corporate banking with CIBC World Markets and Société Générale Canada, Mr. Bache managed client relationships, arranged debt and equity financings and provided M&A and risk management advisory services to mining and metals, oil & gas, manufacturing and financial service companies.